HPS Pharmacies wish to advise that Pfizer is anticipating a supply interruption for Edronax® tablets as follows:

Edronax® Tablets
Reboxetine 4mg
ARTG 79745

This supply interruption is expected to occur from mid-August and last until early October 2023.

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact Pfizer on 1800 675 229, or your pharmacist at HPS Pharmacies.


Download PDF

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates